Profile data is unavailable for this security.
About the company
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
- Revenue in USD (TTM)3.67bn
- Net income in USD290.80m
- Incorporated1980
- Employees15.00k
- LocationCooper Companies Inc6101 Bollinger Canyon Road, Suite 500SAN RAMON 94583United StatesUSA
- Phone+1 (925) 460-3600
- Fax+1 (510) 460-3649
- Websitehttps://www.coopercos.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teleflex Inc | 3.00bn | 296.02m | 9.56bn | 14.50k | 32.45 | 2.12 | 17.57 | 3.19 | 6.26 | 6.23 | 63.41 | 95.61 | 0.417 | 2.14 | 6.99 | 206,993.50 | 4.11 | 5.86 | 4.47 | 6.42 | 55.70 | 55.04 | 9.86 | 14.62 | 1.41 | 7.67 | 0.2808 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
| Insulet Corp | 1.70bn | 206.30m | 12.21bn | 3.00k | 61.90 | 16.64 | 43.76 | 7.20 | 2.82 | 2.82 | 22.78 | 10.48 | 0.7014 | 1.43 | 6.00 | 565,700.00 | 8.53 | 2.71 | 10.26 | 3.14 | 68.35 | 65.81 | 12.16 | 4.28 | 2.62 | 40.74 | 0.659 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
| Shockwave Medical Inc | 730.23m | 147.28m | 12.39bn | 1.47k | 85.62 | 18.28 | 78.61 | 16.97 | 3.86 | 3.86 | 19.13 | 18.08 | 0.66 | 1.04 | 7.86 | 497,431.90 | 13.31 | 10.29 | 14.40 | 11.39 | 86.94 | 84.69 | 20.17 | 15.14 | 10.73 | 19.70 | 0.5226 | 0.00 | 49.11 | 126.45 | -31.81 | -- | 72.88 | -- |
| Hologic Inc | 3.96bn | 466.50m | 17.97bn | 6.99k | 39.37 | 3.71 | 22.88 | 4.54 | 1.94 | 1.94 | 16.30 | 20.64 | 0.4361 | 2.66 | 5.82 | 566,609.40 | 5.14 | 11.40 | 5.74 | 13.38 | 55.12 | 60.29 | 11.78 | 20.95 | 3.29 | -- | 0.345 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
| Cooper Companies Inc | 3.67bn | 290.80m | 18.02bn | 15.00k | 91.60 | 2.34 | 27.07 | 4.91 | 0.9896 | 0.9896 | 7.36 | 38.73 | 0.3108 | 1.77 | 5.95 | 244,420.00 | 2.47 | 10.06 | 2.68 | 11.34 | 66.09 | 65.54 | 7.93 | 29.00 | 1.08 | 4.92 | 0.2649 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
| Baxter International Inc | 14.89bn | -38.00m | 18.79bn | 60.00k | -- | 2.30 | 15.04 | 1.26 | -0.0762 | 5.21 | 29.33 | 16.04 | 0.5311 | 3.21 | 5.71 | 248,200.00 | -0.107 | 0.1942 | -0.1338 | 0.2333 | 36.31 | 38.20 | -0.2015 | 0.3674 | 1.01 | 3.58 | 0.625 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Steris PLC | 5.41bn | 566.84m | 20.54bn | 17.00k | 36.64 | 3.20 | 18.00 | 3.80 | 5.67 | 5.67 | 54.18 | 64.93 | 0.4864 | 3.94 | 6.05 | 318,081.40 | 5.11 | 3.99 | 5.54 | 4.37 | 43.60 | 43.41 | 10.50 | 7.90 | 1.49 | 6.42 | 0.3399 | 49.05 | 8.13 | 13.61 | -56.12 | -17.02 | 16.95 | 8.74 |
| Align Technology, Inc. | 3.92bn | 462.28m | 21.66bn | 21.61k | 47.42 | 5.76 | 46.70 | 5.53 | 6.07 | 6.07 | 51.44 | 49.96 | 0.6497 | 3.96 | 4.27 | 181,237.60 | 7.67 | 16.34 | 11.51 | 24.14 | 70.06 | 71.72 | 11.80 | 23.16 | 1.09 | -- | -- | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Zimmer Biomet Holdings Inc | 7.45bn | 963.80m | 25.00bn | 18.00k | 26.34 | 1.99 | 12.99 | 3.35 | 4.62 | 4.62 | 35.72 | 61.24 | 0.3491 | 0.9052 | 5.27 | 414,027.80 | 4.52 | 2.21 | 5.14 | 2.52 | 71.89 | 71.25 | 12.95 | 7.28 | 0.802 | 7.32 | 0.315 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| West Pharmaceutical Services Inc. | 2.93bn | 568.70m | 26.59bn | 10.60k | 48.12 | 9.94 | 38.33 | 9.08 | 7.58 | 7.58 | 39.09 | 36.72 | 0.7995 | 4.20 | 5.65 | 276,283.00 | 15.08 | 15.61 | 17.99 | 18.65 | 37.15 | 38.06 | 18.86 | 18.47 | 1.95 | -- | 0.0714 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 22.10m | 11.12% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 9.79m | 4.93% |
| Veritas Asset Management LLPas of 31 Dec 2023 | 8.95m | 4.50% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 8.47m | 4.26% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 7.34m | 3.69% |
| Kayne Anderson Rudnick Investment Management LLCas of 31 Dec 2023 | 6.96m | 3.50% |
| Capital Research & Management Co. (World Investors)as of 31 Dec 2023 | 5.63m | 2.83% |
| AllianceBernstein LPas of 31 Dec 2023 | 4.84m | 2.44% |
| Geode Capital Management LLCas of 31 Dec 2023 | 4.50m | 2.27% |
| Generation Investment Management LLPas of 31 Dec 2023 | 4.47m | 2.25% |
